Oncolytics Biotech Inc (ONCY) stock
ONCYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 10-Q on Nov 13, 2026Score 0/30
$0.44+0.06 (+15.11%)
Close on Nov 18, 2026Market cap $56.14MP/E –Yield –
Oncolytics Biotech cash
Cash and short-term investments held at the end of each period.
Oncolytics Biotech's cash was C$15.94M at Dec 31, 2024. For fiscal 2024 it was C$15.94M, down 54.3% from the year before. Over ten years it grew 1.2% a year on average. The highest annual figure on record is C$41.26M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | C$15.94M | -54.3% |
| FY2023 | Dec 31, 2023 | C$34.91M | +199.3% |
| FY2022 | Dec 31, 2022 | C$11.67M | -71.7% |
| FY2021 | Dec 31, 2021 | C$41.26M | +32.2% |
| FY2020 | Dec 31, 2020 | C$31.22M | +120.7% |
| FY2019 | Dec 31, 2019 | C$14.15M | +3.3% |
| FY2018 | Dec 31, 2018 | C$13.70M | +15.7% |
| FY2017 | Dec 31, 2017 | C$11.84M | -1.6% |
| FY2016 | Dec 31, 2016 | C$12.03M | -49.9% |
| FY2015 | Dec 31, 2015 | C$24.02M | +69.7% |
| FY2014 | Dec 31, 2014 | C$14.15M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2024 | Dec 31, 2024 | C$15.94M | -48.9% |
| Q4 FY2023 | Dec 31, 2023 | C$34.91M | +146.8% |
| Q4 FY2022 | Dec 31, 2022 | C$11.67M | -14.8% |
| Q4 FY2021 | Dec 31, 2021 | C$41.26M | +248.6% |
| Q4 FY2020 | Dec 31, 2020 | C$31.22M | +159.4% |
| Q4 FY2019 | Dec 31, 2019 | C$14.15M | -41.1% |
| Q4 FY2018 | Dec 31, 2018 | C$13.70M | -3.2% |
| Q4 FY2017 | Dec 31, 2017 | C$11.84M | – |
| Q4 FY2016 | Dec 31, 2016 | C$12.03M | – |
| Q4 FY2015 | Dec 31, 2015 | C$24.02M | – |
| Q4 FY2014 | Dec 31, 2014 | C$14.15M | – |
See a number that looks wrong?